SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rubra Medicaments informs about closure of trading window

03 Jan 2022 Evaluate

Rubra Medicaments has informed that pursuant to the Company's Securities Dealing Code, the Trading Window for dealing in the Company's Equity Shares will remain closed from Saturday, January 1, 2022 for all Designated Employees of the Company. The closure is in connection with the declaration of financial results of the Company for the quarter ending December 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Centuple Global Share Price

41.31 -0.87 (-2.06%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 247.05
Amrapali Industries 18.64
Adani Enterprises 2972.80
Rashi Peripheral 539.45
PDS 319.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×